You searched for "TINNET"

403 results found

COVID-19 tracheostomies

This is a review of tracheostomies completed by an OMFS Unit in London from 10 March to 18 May 2020. A total of 176 COVID-19 patients were admitted to intensive care, 72 of which required tracheostomy due to prolonged respiratory...

How can we manage children with poor speech discrimination but with normal audiogram

We often come across children and young adults brought in for consultation for suspected hearing loss and having hearing difficulty in noisy backgrounds but who often have normal audiograms. Such patients are suspected to have auditory neuropathy. The term auditory...

Low-frequency air-bone gaps appear to be a true audiological finding in Ménière’s disease

There is a lack of established objective tests in Ménière’s disease (MD) that can provide information about the disease process. The appearance of low-frequency air-bone gaps (LFABGs) in MD is a recognised but unexplored phenomenon. Two theories have been suggested...

Endoscopic approach to the internal auditory canal (IAC)

The otoendoscope, with its wide-angle visualisation, has made it an increasingly popular tool to perform outer, middle and even inner ear surgery. Approaches to the IAC with the endoscope have been described by several authors. In this paper, Valente et...

Not to be mis-underestimated

It is a very rare occurrence to find a paper looking at NF2 and the auditory system. There seems to only be a couple on NF2 prevalence in the population, so this is unsurprising. As far as I can recall...

Implantation Otology & Inner Ear Therapeutics Issue I

To skip directly to features, click the links below: Welcome from the editor - by Prof Manohar Bance Industry News Genomic therapies for hearing loss - by Manohar Bance Cell-based therapies - by Jennifer Harre, Athanasia Warnecke, Hinrish Staecker, Eva...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Cochlear implants and therapeutics: a natural partnership?

Global awareness of cochlear implants as a solution for hearing loss is slowly increasing and gaining acceptance. The potential for combining cochlear implants with inner ear therapeutics is immense, with promise in several areas. This article takes us on a...

Innovative approaches to treating deafness

Shahar Taiber and Karen Avraham give us a summary of gene therapies for hearing loss, with an overview of limitations and what the future holds. Hearing loss is the most common sensory disorder. The last two decades have seen a...

Can we prevent chronic rhinosinusitis?

The old adage ‘prevention is better than cure’ is considered by Professor Hopkins in respect to chronic rhinosinusitis, a condition affecting around 10% of the adult population and associated with huge impact on quality of life and economic cost. A...

Gene therapy restores baby’s hearing

The guest editor of a forthcoming supplement for ENT & Audiology News has helped enable a baby girl born deaf to hear unaided for the first time.

Precision and personalised genomic and epigenomic medicine in audiology/hearing loss

A detailed look at the pathogenesis of acquired hearing loss due to exposure to ototoxicity during pregnancy or shortly after birth. Insights from genomic medicine have shown that, along with environmental factors causing epigenetic alterations, hearing loss may be caused...